PD-1, the key coinhibitory receptor on activated T cells, interacts with overexpressed PD-L1 on cancer cells, tumor-infiltrating lymphocytes, and stroma cells to inhibit T cell proliferation and function (154). Here, PDCD1 is linked to cancer.